XML 32 R17.htm IDEA: XBRL DOCUMENT v3.6.0.2
Share-Based Compensation Plan
12 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation Plan
Share-Based Compensation Plan

The Company sponsored one share-based compensation plan, the 2006 Equity Compensation Plan, which provided for the granting of stock options, stock appreciation rights, stock awards, performance share awards, incentive awards, and stock units.  The 2006 Equity Compensation Plan was approved by the Company’s shareholders at the Annual Meeting held on April 26, 2006, and has succeeded the Company’s 1997 Stock Incentive Plan. The plan expired by its own terms in February 2016, before which, the Company granted share-based compensation to its directors, officers, employees, and other persons the Company determined to have contributed to the profits or growth of the Company.  The number of shares reserved for issuance totaled 430,000 shares.

The Company granted 49,100 shares of restricted stock during 2016 to certain employees and executive officers. Of the 49,100 shares, 31,750 shares are in the form of performance-accelerated restricted stock and 17,350 shares are in the form of time-based restricted stock. During 2016, the Company's board of directors also awarded 11 directors 400 shares of restricted stock for a total of 4,400 restricted shares. These shares will vest at 100% in April 2017.

For the performance-accelerated restricted stock granted to certain employees and executive officers, in order for a recipient to earn and have vested 100% of granted shares, the Company must achieve certain financial performance targets during predefined monitoring periods as compared to a selected peer group and the recipient must be employed by the Company or one of its subsidiaries at the end of the predefined vesting period. Vested shares are distributed to recipients immediately after performance targets are certified. Partial share vesting may be achieved for interim periods during the predefined monitoring periods, however no vesting may occur before the end of 2018. If any shares remain unvested, 50% of the unvested shares will be forfeited. Any remaining shares vest at the end of the predefined monitoring period provided that the recipient remained employed by the Company or one of its subsidiaries over the entire performance and vesting period.

For the time-based restricted stock granted to certain employees and executive officers, in order for a recipient to earn and have vested 100% of the granted shares, the recipient must be employed by the Company or one of its subsidiaries at the time of vesting.
For the years ended December 31, 2016, 2015, and 2014, the Company recorded $925,000, $605,000, and $426,000, respectively, in share-based compensation expense related to restricted stock and option grants.  The total income tax benefit related to share-based compensation was $5,000, $117,000, and $63,000 in 2016, 2015, and 2014, respectively.

The following table summarizes restricted stock awarded under the 2006 Equity Compensation Plan:
 
December 31,
 
2016
 
2015
 
2014
(Dollars in thousands)
Shares
 
Weighted-Average Grant Date Fair Value
 
Aggregate Value
 
Shares
 
Weighted-Average Grant Date Fair Value
 
Aggregate Value
 
Shares
 
Weighted-Average Grant Date Fair Value
 
Aggregate Value
Non-vested at the beginning of the year
153,399

 
$
17.17

 
 
 
134,108

 
$
16.66

 
 
 
119,250

 
$
16.39

 
 
Granted
53,500

 
20.76

 
 
 
36,150

 
18.50

 
 
 
41,533

 
17.65

 
 
Vested
(53,908
)
 
16.88

 
 
 
(16,359
)
 
15.91

 
 
 
(15,425
)
 
15.59

 
 
Forfeited or expired
(2,250
)
 
19.91

 
 
 
(500
)
 
18.07

 
 
 
(11,250
)
 
16.05

 
 
Non-vested at end of the year
150,741

 
$
18.50

 
$
5,238

 
153,399

 
$
17.17

 
$
2,835

 
134,108

 
$
16.66

 
$
2,415



The weighted-average remaining contractual term for non-vested grants at December 31, 2016, 2015, and 2014 was 2.5 , 2.7, and 3.5 years, respectively.  As of December 31, 2016, there was $1.6 million of total unrecognized compensation expense related to the non-vested service awards granted under the 2006 Equity Compensation Plan.

Stock options may be granted periodically to certain officers and employees under the Company’s share-based compensation plan at prices equal to the market value of the stock on the date the options are granted.  Options granted vest over a three-year time period over which 25% vests on each of the first and second anniversaries of the grant and 50% on the third anniversary of the grant. As of December 31, 2016, all outstanding option awards were vested and, accordingly, there was no unrecognized compensation expense related to unvested stock-based option awards. Shares issued in connection with stock option exercises may be issued from available treasury shares or from market purchases. There were no stock option awards granted during the years ended December 31, 2016, 2015 or 2014.

The following table summarizes options outstanding under the 2006 Equity Compensation Plan at the end of the reportable periods:  
 
2016
 
2015
 
2014
 
Shares
 
Weighted-
Average
Exercise
Price
 
Shares
 
Weighted-
Average
Exercise
Price
 
Shares
 
Weighted-
Average
Exercise
Price
Outstanding at beginning of year
30,012

 
$
14.00

 
30,012

 
$
14.00

 
58,513

 
$
15.30

Granted

 

 

 

 

 

Exercised
(6,650
)
 
14.00

 

 

 
(25,501
)
 
14.00

Forfeited or expired

 

 

 

 
(3,000
)
 
39.40

Outstanding at end of year
23,362

 
$
14.00

 
30,012

 
$
14.00

 
30,012

 
$
14.00

Options exercisable at year end
23,362

 
$
14.00

 
30,012

 
$
14.00

 
30,012

 
$
14.00



The total intrinsic value of options exercised was $88,000 and $126,500 during 2016 and 2014, respectively. There were no options exercised during 2015. There was $484,800, $134,500, and $120,300 aggregate intrinsic value of options outstanding at December 31, 2016, 2015 and 2014, respectively.

The aggregate intrinsic value represents the amount by which the current market value of the underlying stock exceeds the exercise price. This amount changes based on changes in the market value of the Company’s common stock.

As of December 31, 2016, options outstanding and exercisable are summarized as follows:
Range of Exercise Prices
 
Options Outstanding
 
Weighted-Average Remaining Contractual Life (years)
 
Options Exercisable
$
14.00

 
18,362

 
2.22
 
18,362

$
14.00

 
5,000

 
2.85
 
5,000

$
14.00

 
23,362

 
2.36
 
23,362